321 results on '"López-Campos, José Luis"'
Search Results
2. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial
3. COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients
4. Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
5. Prevalence of genetic mutations in alpha-1 antitrypsin deficiency (aatd) in patients with chronic obstructive pulmonary disease in Colombia
6. Sex-Differences in Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry
7. Inhaled Maintenance Therapy in the Follow-Up of COPD in Outpatient Respiratory Clinics. Factors Related to Inhaled Corticosteroid Use. EPOCONSUL 2021 Audit
8. Resultados de la implementación de un programa de detección de casos de déficit de alfa-1 antitripsina en pacientes con EPOC
9. Variations in Chronic Obstructive Pulmonary Disease Outpatient Care in Respiratory Clinics: Results From the 2021 EPOCONSUL Audit
10. Evaluation of the Diagnostic Accuracy of Non-Specific Bronchial Provocation Tests in the Diagnosis of Asthma: A Randomized Cross-Over Study
11. CFTR dysfunction and targeted therapies: A vision from non-cystic fibrosis bronchiectasis and COPD
12. [Translated article] Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care
13. [Translated article] Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update
14. Actualización de la Guía Española de la EPOC (GesEPOC): comorbilidades, automanejo y cuidados paliativos
15. Actualización 2021 de la Guía Española de la EPOC (GesEPOC). Tratamiento no farmacológico
16. Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry
17. [Translated article] Spanish COPD Guidelines (GesEPOC) 2021 Update. Diagnosis and Treatment of COPD Exacerbation Syndrome
18. Actualización 2021 de la guía española de la EPOC (GesEPOC). Diagnóstico y tratamiento del síndrome de agudización de la EPOC
19. [Translated article] Spanish COPD guidelines (GesEPOC) 2021: Updated pharmacological treatment of stable COPD
20. [Translated article] Deconstructing phenotypes in COPD: An analysis of the TRACE cohort
21. Actualización 2021 de la Guía Española de la EPOC (GesEPOC). Tratamiento farmacológico de la EPOC estable
22. Deconstruyendo los fenotipos en la EPOC: un análisis de la cohorte TRACE
23. A Pilot Study on Proteomic Predictors of Mortality in Stable COPD.
24. Knowledge of chronic obstructive pulmonary disease, presence of chronic respiratory symptoms and use of spirometry among the Spanish population: CONOCEPOC 2019 study
25. Conocimiento de la enfermedad pulmonar obstructiva crónica, presencia de síntomas respiratorios crónicos y uso de la espirometría en la población española: estudio CONOCEPOC 2019
26. COPD: systemic proteomic profiles in frequent and infrequent exacerbators
27. Global mortality and readmission rates following COPD exacerbation-related hospitalization: a meta-analysis of 65945 individual patients
28. Detection of Alpha-1 Antitrypsin Levels in Chronic Obstructive Pulmonary Disease in Respiratory Clinics in Spain: Results of the EPOCONSUL 2021 Audit
29. Recomendaciones SEPAR sobre la vacuna COVID-19 en las enfermedades respiratorias
30. The Beginning of the Trend Change in Lung Cancer Mortality Trends in Spain, 1980–2018
31. Results of a Diagnostic Procedure Based on Multiplex Technology on Dried Blood Spots and Buccal Swabs for Subjects With Suspected Alpha1 Antitrypsin Deficiency
32. Comparaciones entre asociaciones de broncodilatadores de larga duración para la enfermedad pulmonar obstructiva crónica
33. Soporte telefónico al paciente con EPOC en tiempos de la COVID-19
34. Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease
35. Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin
36. Smoking and COPD Knowledge in the General Spanish Population: A CONOCEPOC Study
37. Incidence of Interstitial Lung Diseases in the South of Spain 1998-2000: The RENIA Study
38. The variability of respiratory symptoms and associated factors in COPD
39. The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO.
40. Consensus on the Management of the COPD Patient in the COVID-19 Setting: COPD Forum Working Group
41. In Search for Simplicity: Quantifying the Diagnostic Algorithm of Hypersensitivity Pneumonitis
42. Randomized trial of non-invasive ventilation combined with exercise training in patients with chronic hypercapnic failure due to chronic obstructive pulmonary disease
43. Demographic and clinical characteristics of patients with α1-antitrypsin deficiency genotypes PI*ZZ and PI*SZ in the Spanish registry of EARCO
44. Inflammatory response in human lung cells stimulated with plasma from COPD patients
45. Determinants in the Underdiagnosis of COPD in Spain—CONOCEPOC Study
46. The Human Mycobiome in Chronic Respiratory Diseases: Current Situation and Future Perspectives
47. Factors associated with high healthcare resource utilisation among COPD patients
48. [Translated article] Smoking Cessation Units as a Source of COPD Diagnoses: Project 1000-200
49. Las unidades de deshabituación tabáquica como oportunidad para el diagnóstico de EPOC: el proyecto 1000-200
50. Efficacy and Safety of Single-inhaler Triple Therapy Containing Dual Bronchodilator With Corticosteroids Compared to Monotherapy, Dual Therapy, or Open Triple Therapy in Moderate/Severe COPD: A Systematic Literature Review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.